Pharmaceutical Composition Comprising Udenafil

Patent No. EP4005556 (titled "Pharmaceutical Composition Comprising Udenafil") was filed by Corepharm BIO on Jul 24, 2020. The application was issued on Feb 19, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANNov 19, 2025FINNEGAN EUROPE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4005556

COREPHARM BIO
Application Number
EP20848224A
Filing Date
Jul 24, 2020
Status
Granted And Under Opposition
Jan 17, 2025
Publication Date
Feb 19, 2025